Passa al contenuto
Merck

BPS80584

PARPtrap Assay Kit for PARP1

Sinonimo/i:

Assay Kits, ADPRT, poly (ADP-ribose) polymerase 1, poly(ADP-ribosyl)transferase

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione

Informazioni su questo articolo

eCl@ss:
32160702
UNSPSC Code:
41116100
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


manufacturer/tradename

BPS Bioscience

technique(s)

activity assay: suitable (Fluorescence Polarization)

UniProt accession no.

shipped in

dry ice

storage temp.

-65 to -96°C

General description

The PARPtrap Assay Kit for PARP1 is a fluorescence polarization (FP), homogeneous, 96-well or 384-well assay designed for screening and profiling small molecules that trap PARP1 onto DNA and complex formation in a high throughput screening (HTS) format. The PARPtrap Assay Kit for PARP1 comes in a convenient 96-well or 384-well format, with purified recombinant PARP1 enzyme, a fluorescent-labeled oligonucleotide duplex, NAD+ and PARPtrap assay buffer for 100 or 400 enzyme reactions.

Application

Screen small molecules that enhance PARP1/DNA trapping for drug discovery and high throughput screening (HTS) applications, and IC50 determination.


PARP1, also known as poly-(ADP-ribose) polymerase 1 or NAD+ ADP-ribosyltransferase 1, is part of the PARP family, and it is the most abundant member. ADP ribosylation, which is the addition of an ADP-ribose to a protein, is a reversible post-translational modification of proteins mostly involved in the DNA Damage Response (DDR) pathway. Poly-ADP-ribosylation (termed PARylation) is the addition of linear or branched chains of ADP-ribose. PARP1 participates in DNA repair by non-homologous end joining (NHEJ), homologous recombination (HR), microhomology-mediated end-joining (MMEJ) and nucleotide excision repair. Dysfunction of DDR pathways can lead to oncogenesis. Overexpression of PARP1 has been found in breast and colon cancer, neuroblastoma, and others. This overexpression can lead to increasing MMEJ, an error-prone DNA repair mechanism, and genome instability leading to cancer. In addition to being involved in DDR, PARP1 is also linked to inflammation and type I diabetes. PARP1 is known to bind damaged DNA through its DNA-binding domains. Binding to DNA activates PARP1 and in the presence of NAD+ PARP1 ribosylates itself (auto-ribosylation), what in consequence leads to PARP1 dissociation from the DNA due to the accumulated negative charge of the ribosyl polymer. In the presence of some inhibitors, however, PARP remains bound to DNA, a phenomenon termed trapping. Trapped PARP-DNA complexes have been shown to be highly cytotoxic to cancer cells, therefore such inhibitors may be desirable for cancer treatment. Further understanding of the molecular pathways involving PARP1, and this contribution to disease, will continue to pave the way for new therapies for PARP1-linked diseases.


Datasheet and Protocols for the 96 reaction kit may be found here.

Datasheet an Protocols for the 384 reactoin kit may be found here.


Classe di stoccaggio

10 - Combustible liquids

WGK

WGK 1



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti